tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tango Therapeutics reports Q2 EPS (35c), consensus (34c)
PremiumThe FlyTango Therapeutics reports Q2 EPS (35c), consensus (34c)
1M ago
Tango Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Tango Therapeutics management to meet with Cantor Fitzgerald
2M ago
Tango Therapeutics announces first patient dosed in Phase 1/2 trial of TNG462
Premium
The Fly
Tango Therapeutics announces first patient dosed in Phase 1/2 trial of TNG462
3M ago
Tango Therapeutics: Promising Developments and Strategic Focus Justify Buy Rating
PremiumRatingsTango Therapeutics: Promising Developments and Strategic Focus Justify Buy Rating
4M ago
Tango Therapeutics Extends Cash Runway Amid Clinical Progress
Premium
Company Announcements
Tango Therapeutics Extends Cash Runway Amid Clinical Progress
4M ago
Tango Therapeutics files $400M mixed securities shelf
Premium
The Fly
Tango Therapeutics files $400M mixed securities shelf
4M ago
Tango Therapeutics Advances Cancer Treatment Pipeline
PremiumCompany AnnouncementsTango Therapeutics Advances Cancer Treatment Pipeline
7M ago
Tango Therapeutics reports Q4 EPS (35c), consensus (34c)
Premium
The Fly
Tango Therapeutics reports Q4 EPS (35c), consensus (34c)
7M ago
Tango Therapeutics sees cash runway into 3Q26
Premium
The Fly
Tango Therapeutics sees cash runway into 3Q26
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100